These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25855413)

  • 1. Outcome and toxicities associated to chemotherapy in children with acute lymphoblastic leukemia and Gilbert syndrome. Usefulness of UGT1A1 mutational screening.
    Berrueco R; Alonso-Saladrigues A; Martorell-Sampol L; Català-Temprano A; Ruiz-Llobet A; Toll T; Torrebadell M; Naudó M; Camós M; Rives S
    Pediatr Blood Cancer; 2015 Jul; 62(7):1195-201. PubMed ID: 25855413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy-induced unconjugated hyperbilirubinemia caused by a mutation of the bilirubin uridine-5'-diphosphate-glucuronosyltransferase gene.
    Maruo Y; Sato H; Bamba N; Iwai M; Sawa H; Fujino H; Taga T; Ota S; Shimada M
    J Pediatr Hematol Oncol; 2001 Jan; 23(1):45-7. PubMed ID: 11196269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncology Drug Dosing in Gilbert Syndrome Associated with UGT1A1: A Summary of the Literature.
    Ha VH; Jupp J; Tsang RY
    Pharmacotherapy; 2017 Aug; 37(8):956-972. PubMed ID: 28494109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of UGT1A1 variations to chemotherapy-induced unconjugated hyperbilirubinemia in pediatric leukemia patients.
    Nomura A; Maruo Y; Taga T; Takeuchi Y
    Pediatr Res; 2016 Aug; 80(2):252-7. PubMed ID: 27057738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia.
    Evans WE; Relling MV; Rodman JH; Crom WR; Boyett JM; Pui CH
    N Engl J Med; 1998 Feb; 338(8):499-505. PubMed ID: 9468466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
    Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
    Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical UGT1A1 Genetic Analysis in Pediatric Patients: Experience of a Reference Laboratory.
    Moyer AM; Skierka JM; Kotzer KE; Kluge ML; Black JL; Baudhuin LM
    Mol Diagn Ther; 2017 Jun; 21(3):327-335. PubMed ID: 28213806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A homozygous mutation in UGT1A1 exon 5 may be responsible for persistent hyperbilirubinemia in a Japanese girl with Gilbert's syndrome.
    Nakagawa T; Mure T; Yusoff S; Ono E; Kusuma Harahap IS; Morikawa S; Morioka I; Takeshima Y; Nishio H; Matsuo M
    Kobe J Med Sci; 2011 Jul; 57(1):E26-31. PubMed ID: 22169899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gilbert's syndrome and hyperbilirubinemia in protease inhibitor therapy--an extended haplotype of genetic variants increases risk in indinavir treatment.
    Lankisch TO; Behrens G; Ehmer U; Möbius U; Rockstroh J; Wehmeier M; Kalthoff S; Freiberg N; Manns MP; Schmidt RE; Strassburg CP
    J Hepatol; 2009 May; 50(5):1010-8. PubMed ID: 19303655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms of bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert's syndrome as well as in healthy Japanese subjects.
    Takeuchi K; Kobayashi Y; Tamaki S; Ishihara T; Maruo Y; Araki J; Mifuji R; Itani T; Kuroda M; Sato H; Kaito M; Adachi Y
    J Gastroenterol Hepatol; 2004 Sep; 19(9):1023-8. PubMed ID: 15304120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A high frequency of Gilbert syndrome (UGT1A1*28/*28) and associated hyperbilirubinemia but not cholelithiasis in adolescent and adult north Indian patients with transfusion-dependent β-thalassemia.
    Shrestha O; Khadwal AR; Singhal M; Trehan A; Bansal D; Jain R; Pal A; Hira JK; Chhabra S; Malhotra P; Das R; Sharma P
    Ann Hematol; 2020 Sep; 99(9):2019-2026. PubMed ID: 32676731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of maximum supportive care on dose compliance and survival. Single-center analysis of childhood acute lymphoblastic leukemia and non-Hodgkin's-lymphoma treated within 1984-1993.
    Urban C; Benesch M; Lackner H; Schwinger W; Kerbl R; Gadner H
    Klin Padiatr; 1997; 209(4):235-42. PubMed ID: 9293456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation.
    Marshall GM; Dalla Pozza L; Sutton R; Ng A; de Groot-Kruseman HA; van der Velden VH; Venn NC; van den Berg H; de Bont ES; Maarten Egeler R; Hoogerbrugge PM; Kaspers GJ; Bierings MB; van der Schoot E; van Dongen J; Law T; Cross S; Mueller H; de Haas V; Haber M; Révész T; Alvaro F; Suppiah R; Norris MD; Pieters R
    Leukemia; 2013 Jul; 27(7):1497-503. PubMed ID: 23407458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
    Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
    Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.
    Möricke A; Zimmermann M; Reiter A; Gadner H; Odenwald E; Harbott J; Ludwig WD; Riehm H; Schrappe M
    Klin Padiatr; 2005; 217(6):310-20. PubMed ID: 16307416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UGT1A1 genetic analysis as a diagnostic aid for individuals with unconjugated hyperbilirubinemia.
    Skierka JM; Kotzer KE; Lagerstedt SA; O'Kane DJ; Baudhuin LM
    J Pediatr; 2013 Jun; 162(6):1146-52, 1152.e1-2. PubMed ID: 23290513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Gilbert's-like" syndrome as part of a spectrum of persistent unconjugated hyperbilirubinemia in post-chronic hepatitis patients.
    Ye J; Cui L; Zhou Y; Huang Y; Banafa O; Hou X; Ding Z; Lin R
    Sci Rep; 2018 Jan; 8(1):2008. PubMed ID: 29386646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic uptake of organic anions affects the plasma bilirubin level in subjects with Gilbert's syndrome mutations in UGT1A1.
    Persico M; Persico E; Bakker CT; Rigato I; Amoroso A; Torella R; Bosma PJ; Tiribelli C; Ostrow JD
    Hepatology; 2001 Mar; 33(3):627-32. PubMed ID: 11230743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal residual disease-based augmented therapy in childhood acute lymphoblastic leukemia: a report from the Japanese Childhood Cancer and Leukemia Study Group.
    Yamaji K; Okamoto T; Yokota S; Watanabe A; Horikoshi Y; Asami K; Kikuta A; Hyakuna N; Saikawa Y; Ueyama J; Watanabe T; Okada M; Taga T; Kanegane H; Kogawa K; Chin M; Iwai A; Matsushita T; Shimomura Y; Hori T; Tsurusawa M;
    Pediatr Blood Cancer; 2010 Dec; 55(7):1287-95. PubMed ID: 20535816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment outcome of adolescents with acute lymphoblastic leukemia.
    Irken G; Oren H; Gülen H; Duman M; Uçar C; Atabay B; Yilmaz S; Uysal K; Cevik N
    Ann Hematol; 2002 Nov; 81(11):641-5. PubMed ID: 12454702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.